Instructors
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
Christie Bartels, MD, MS, Assistant Professor, Divison of Rheumatology, School of Medicine and Public Health, UW-Madison, Madison, WI
Financial Relationship Disclosure: Pfizer (Grant)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Poonam Beniwal-Patel, MD, Assistant Professor, Division of Gastroenterology & Hepatology, Medical College of Wisconsin and Froedtert Hospital, Milwaukee, WI
Financial Relationship Disclosure: Takeda Pharmaceutical (Contractor)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Angela Considine, PharmD, BCGP, CSP, Supervisor, Specialty Pharmacy, Swedish American Hospital, Rockford, IL
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Leslie Dickmann, PhD, MPH, Program Director, Division of Pharmacy Professional Development, UW-Madison School of Pharmacy, Madison, WI
Financial Relationship Disclosure: Genentech (Employment, Stock)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Shivani Garg, MD, MS, Assistant Professor, Division of Rheumatology, School of Medicine and Public Health, UW-Madison, Lupus Nephritis Clinic, UW Health, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Rebecca Georgia, ND, Family Clinic of Natural Medicine, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Mary S. Hayney, PharmD, MPH, FCCP, BCPS, Professor (CHS), Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI
Financial Relationship Disclosure: Takeda Medical Research Foundation (Grant), Sanofi Pasteur (Grant)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Aaron Henkel, ND, Family Clinic of Natural Medicine, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes
Sara McCoy, MD, Assistant Professor, Division of Pheumatology, UW Health Sjögren’s Syndrome Clinic, Madison, WI
Financial Relationship Disclosure: Bristol-Myers Squibb (Contractor)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Natalie Schmitz, PharmD, PhD, Assistant Professor, Pharmacy Practice Division, UW-Madison, School of Pharmacy, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes
Planning Committee
Leslie Dickmann, PhD, MPH, Program Director, Division of Pharmacy Professional Development, UW-Madison School of Pharmacy, Madison, WI
Financial Relationship Disclosure: See above
Mary Hayney, RPh, PharmD, MPH, BCPS, Professor (CHS), Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI
Development, UW-Madison School of Pharmacy, Madison, WI
Financial Relationship Disclosure: See above
Chandra Norder-Brandli, DNP, AG-ACNP, FNP, APNP, Clinical Assistant Professor, Adult Gero Acute Care Pop Lead, UW-Madison, School of Nursing, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Natalie Schmitz, PhD, PharmD, Assistant Professor (CHS), Pharmacy Practice Division, UW-Madison School of Pharmacy, Madison, WI
Development, UW-Madison School of Pharmacy, Madison, WI
Financial Relationship Disclosure: See above
CE Credit
Accreditation Statement
In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin–Madison ICEP designates this enduring knowledge based activity for 7.0 hours or 0.7 CEUs of CPE credit. Credit can be earned by successfully completing the activity, the assessment and the evaluation. There will be no partial credit awarded for partial completion.
JA0000358-0000-21-086-H01-P
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.70 CEUs or 7.0 hours.